Xu Liang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Metastatic Breast Cancer

Radiation Therapy

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Liang, Linhui Zhang, Xinyu Gui, Lijun Di, Huiping Li, Guohong Song
Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis. Cancer (2024)
Xu Liang, Linhui Zhang, Xinyu Gui, Lijun Di, Huiping Li, Guohong Song
Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis. Cancer 130 (S8) (2024)
Xu Liang, Linhui Zhang, Xinyu Gui, Lijun Di, Huiping Li, Guohong Song
Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis. Cancer 130 (S8) (2024)
Xu Liang, Xinyu Gui, Ying Yan, Lijun Di, Xiaoran Liu, Huiping Li, Guohong Song
Long-term Outcome Analysis of Pyrotinib in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: A Real-World Study. The oncologist (2023)
Xin-Yu Gui, Xu Liang, Huiping Li
Effectiveness, safety, and impact on quality of life of eribulin-based therapy in heavily pretreated patients with metastatic breast cancer: A real-world analysis. Cancer medicine (2023)